Filing Details
- Accession Number:
- 0001140361-23-053861
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-17 16:06:49
- Reporting Period:
- 2023-11-15
- Accepted Time:
- 2023-11-17 16:06:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1220363 | Md L Robert Zerbe | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-15 | 200 | $38.00 | 33,195 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-15 | 100 | $38.06 | 33,095 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023.